NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.

IF 14.8 2区医学 Q1 ONCOLOGY

Journal of the National Comprehensive Cancer Network Pub Date : 2024-09-01 DOI:10.6004/jnccn.2024.0047

Reid M Ness, Xavier Llor, Mohammad Ali Abbass, Shrinivas Bishu, Christopher T Chen, Gregory Cooper, Dayna S Early, Mark Friedman, David Fudman, Francis M Giardiello, Kathryn Glaser, Surya Gurudu, Michael Hall, Lyen C Huang, Rachel Issaka, Bryson Katona, Trilokesh Kidambi, Audrey J Lazenby, Jennifer Maratt, Arnold J Markowitz, Joseph Marsano, Folasade P May, Robert J Mayer, Kinga Olortegui, Swati Patel, Shajan Peter, Laura D Porter, Mehnaz Shafi, Peter P Stanich, Jonathan Terdiman, Peter Vu, Jennifer M Weiss, Elizabeth Wood, Carly J Cassara, Vaishnavi Sambandam

{"title":"NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.","authors":"Reid M Ness, Xavier Llor, Mohammad Ali Abbass, Shrinivas Bishu, Christopher T Chen, Gregory Cooper, Dayna S Early, Mark Friedman, David Fudman, Francis M Giardiello, Kathryn Glaser, Surya Gurudu, Michael Hall, Lyen C Huang, Rachel Issaka, Bryson Katona, Trilokesh Kidambi, Audrey J Lazenby, Jennifer Maratt, Arnold J Markowitz, Joseph Marsano, Folasade P May, Robert J Mayer, Kinga Olortegui, Swati Patel, Shajan Peter, Laura D Porter, Mehnaz Shafi, Peter P Stanich, Jonathan Terdiman, Peter Vu, Jennifer M Weiss, Elizabeth Wood, Carly J Cassara, Vaishnavi Sambandam","doi":"10.6004/jnccn.2024.0047","DOIUrl":null,"url":null,"abstract":"<p><p>The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.</p>","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":null,"pages":null},"PeriodicalIF":14.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2024.0047","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.

查看原文本刊更多论文

NCCN Guidelines® Insights：结直肠癌筛查，1.2024 版。

NCCN 《结直肠癌 (CRC) 筛查指南》介绍了各种结直肠癌筛查方式以及针对偶发性 CRC 平均患病风险或高患病风险患者的建议筛查计划。这些指南旨在帮助医生在对无明确遗传综合征的患者进行 CRC 筛查时做出临床决策。这些 "NCCN 指南透视 "重点介绍了 NCCN 指南的部分最新更新内容，包括有关 CRC 一级和二级预防的章节，并介绍了专家小组就平均风险人群以及因儿童、青少年和青年癌症病史而风险增加的人群开始筛查的年龄所提建议的背景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the National Comprehensive Cancer Network ONCOLOGY-

CiteScore

20.20

自引率

0.00%

发文量

388

审稿时长

4-8 weeks

期刊介绍： JNCCN—Journal of the National Comprehensive Cancer Network is a peer-reviewed medical journal read by over 25,000 oncologists and cancer care professionals nationwide. This indexed publication delivers the latest insights into best clinical practices, oncology health services research, and translational medicine. Notably, JNCCN provides updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), review articles elaborating on guideline recommendations, health services research, and case reports that spotlight molecular insights in patient care. Guided by its vision, JNCCN seeks to advance the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and scientific studies related to oncology health services research. This encompasses quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN boasts indexing by prominent databases such as MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus, reinforcing its standing as a reputable source for comprehensive information in the field of oncology.